COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation
Latest Information Update: 02 May 2024
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Haemorrhage; Stroke
- Focus Therapeutic Use
- Acronyms COBRRA AF; PROBE
- 08 Sep 2021 Status changed from not yet recruiting to recruiting.
- 22 Feb 2021 Planned initiation date changed from 29 Jan 2021 to 15 Mar 2021.
- 01 Dec 2020 New trial record